Vimarsana
Biggest News Aggregation in the World

Ossdsign Catalyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ossdsign Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ossdsign Catalyst Today - Breaking & Trending Today

OssDsign signs contract with 100 VA orthopedic hospitals - Vimarsana News

OssDsign signs contract with 100 VA orthopedic hospitals

"OssDsign secures contract with U.S. Department of Veterans Affairs to provide orthobiologic products to 100 additional VA hospitals nationwide, expanding acces

Interim Report - January-March 2024 - Vimarsana News

Interim Report - January-March 2024

STOCKHOLM – 26 April 2024. Karolinska Development AB today publishes its Interim Report - January-March 2024. The full report is available on the Company's website. “2024 has begun strongly with...

Year-end Report - January-December 2023 - Vimarsana News

Year-end Report - January-December 2023

STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company's website. “2023 has been a year...

12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research - Vimarsana News

12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research

Uppsala, January 24, 2024. OssDsign AB (publ.) today announces that the previously communicated outstanding 12-month results from the clinical study TOP FUSION have been published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research. The results show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with the novel nanosynthetic bone graft OssDsign Catalyst.

Source: di.se
OssDsign reports exceptional data from the clinical study TOP FUSION - Vimarsana News

OssDsign reports exceptional data from the clinical study TOP FUSION

Uppsala, January 9, 2024. OssDsign AB today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 %...